IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
224.90
+7.79 (3.59%)
At close: Nov 21, 2025, 4:00 PM EST
225.00
+0.10 (0.04%)
After-hours: Nov 21, 2025, 7:30 PM EST
IQVIA Holdings Revenue
IQVIA Holdings had revenue of $4.10B in the quarter ending September 30, 2025, with 5.24% growth. This brings the company's revenue in the last twelve months to $15.90B, up 3.85% year-over-year. In the year 2024, IQVIA Holdings had annual revenue of $15.41B with 2.81% growth.
Revenue (ttm)
$15.90B
Revenue Growth
+3.85%
P/S Ratio
2.46
Revenue / Employee
$180,727
Employees
88,000
Market Cap
38.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15.41B | 421.00M | 2.81% |
| Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
| Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
| Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
| Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
IQV News
- 10 days ago - Oakmark Global Concentrated Strategy Q3 2025 Top Contributors And Detractors - Seeking Alpha
- 10 days ago - IQVIA Holdings Inc. (IQV) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 15 days ago - Oakmark Concentrated Strategy: 6 Stocks That Raised Guidance And Drove Innovation - Seeking Alpha
- 16 days ago - Dr. William G. Kaelin Jr. joins IQVIA Board of Directors - Business Wire
- 25 days ago - IQVIA Holdings Inc. (IQV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - IQVIA narrows annual profit forecast amid continued research contract cancellations - Reuters
- 25 days ago - IQVIA Reports Third-Quarter 2025 Results - Business Wire
- 4 weeks ago - Smart Acquisitions And Profit Margin Growth Amid Strategic Repositioning - Seeking Alpha